Markets

Associated Press

Photo Illustration by Scott Olson/Getty Images

Zoom Video Communications Inc (NASDAQ:ZM) is trading higher Friday after Cathie Wood purchased 96,123 shares for the ARK Innovation ETF (NYSE:ARKK). What Happened: On Tuesday, Zoom Video reported quarterly earnings of $1.32 per share, which beat the estimate of 99 cents. The company reported quarterly revenue of $956.2 million, which beat the estimate of $906.03 million. Related Link: Where Zoom Video Communications Stands With Analysts Analyst Assessment: Multiple analyst firms adjusted price targets on Zoom Video Communications following its earnings report: Citigroup analyst Walter Pritchard maintained Zoom Video Communications with a Neutral rating and raised the price target from $362 to $380. UBS analyst Karl Keirstead maintained Zoom Video Communications with a Neutral rating and raised the price target from $325 to $345. Deutsche Bank analyst Matthew Nikam maintained Zoom Video Communications with a Hold rating and raised the price target from $360 to $375. Piper Sandler analyst James Fish maintained Zoom Video Communications with an Overweight rating and lowered the price target from $541 to $464. BTIG analyst Matt VanVliet maintained Zoom Video Communications with a Buy rating and lowered the price target from $550 to $495. JPMorgan analyst Sterling Auty maintained Zoom Video Communications with a Neutral rating and lowered the price target from $385 to $456. Price Action: Zoom Video Communications has traded as high as $588.84 and as low as $196.10 over a 52-week period. At last check

Upgrades According to Argus Research, the prior rating for Diageo PLC (NYSE:DEO) was changed from Hold to Buy. The current stock performance of Diageo shows a 52-week-high of $195.03 and a 52-week-low of $127.12. Moreover, at the end of the last trading period, the closing price was at $192.88. According to DA Davidson, the prior rating for FormFactor Inc (NASDAQ:FORM) was changed from Neutral to Buy. For the first quarter, FormFactor had an EPS of $0.38, compared to year-ago quarter EPS of $0.33. The stock has a 52-week-high of $52.39 and a 52-week-low of $22.37. At the end of the last trading period, FormFactor closed at $33.31. According to Stephens & Co., the prior rating for Dick’s Sporting Goods Inc (NYSE:DKS) was changed from Underweight to Equal-Weight. Dick’s Sporting Goods earned $3.79 in the first quarter, compared to $1.21 in the year-ago quarter. At the moment, the stock has a 52-week-high of $101.30 and a 52-week-low of $34.66. Dick’s Sporting Goods closed at $95.77 at the end of the last trading period. Citigroup upgraded the previous rating for Mirati Therapeutics Inc (NASDAQ:MRTX) from Neutral to Buy. For the first quarter, Mirati Therapeutics had an EPS of $2.67, compared

NEW YORK, June 04, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that Dr. Jaume Mora, M.D., Ph.D. from SJD Barcelona Children’s Hospital will present frontline data for DANYELZA and GM-CSF for consolidation of high-risk neuroblastoma (“HR-NB”) patients in complete remission at the American Society of Clinical Oncology (“ASCO”) Virtual Annual Meeting on June 4, 2021Patients received five cycles of DANYELZA and GM-CSF in a compassionate use setting for consolidation of HR-NB in first or subsequent complete remission (“CR”). DANYELZA was administered in an outpatient setting on days 1, 3 and 5 at 9.0 mg/kg/cycle in combination with GM-CSF, and treatment cycles were repeated every four weeks. From June 2017 to November 2020, a total of 73 patients were treated: 55 patients (75%) in first CR and 18 patients (25%) in second or more CR. The three-year event free survival (“EFS”) for patients in first CR was 74% and 19% for second or later CR. The three-year overall survival (“OS”) for the patients in first CR was 92% and 66% for second or

Breanne Madigan is the chief executive of crypto index provider and trading platform TradeBlock. TradeBlock

SALT LAKE CITY, June 04, 2021 (GLOBE NEWSWIRE) — Paul J. Diaz, president and CEO of Myriad Genetics (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will discuss the company’s transformation plan and growth initiatives during a fireside chat at the Goldman Sachs 2021 Virtual Global Healthcare Conference at 8:50 a.m. EST on June 10, 2021.Diaz will be joined by Bryan Riggsbee, chief financial officer of Myriad Genetics. The presentation will be available via a live audio webcast accessible through the investor section of the Myriad Genetics website at www.myriad.com.About Myriad Genetics Myriad Genetics Inc. is a leading genetic testing and precision medicine company dedicated to advancing health and wellbeing for all, empowering individuals with vital genetic insights and enabling healthcare providers to better detect, treat and prevent disease. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where genetic testing can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.Myriad, the Myriad logo, BART, BRACAnalysis, Colaris, Colaris AP, myRisk, Myriad myRisk, myRisk Hereditary Cancer, myChoice, myPlan, BRACAnalysis CDx, Tumor BRACAnalysis CDx, myChoice CDx, EndoPredict,

Traders and investors braced for the jobs data on Friday. Mark Lennihan/Getty Images

(RTTNews) – French stocks fell slightly in lackluster trade on Friday as strong U.S. economic data released overnight intensified expectations of the likelihood of U.S. Federal Reserve paring back its bond-buying program. While ADP private payrolls surged in May, U.S weekly jobless claims fell below 400,000 last week, indicating a strengthening of the labor market. Separate data from the Institute for Supply Management showed that U.S. service sector activity hit a record high in May. The U.S. nonfarm payrolls report due later in the day might offer more clues on labor market recovery and the direction of policy. The benchmark CAC 40 slid 7 points or 0.1 percent, to 6,501 after declining 0.2 percent in the previous session. Vivendi shares were down half a percent. Hedge-fund billionaire William Ackman’s special-purpose acquisition company, Pershing Square Tontine Holdings Ltd. (PSTH), confirmed that it is in discussions with the French media giant to acquire 10 percent of the outstanding ordinary shares of Universal Music Group B.V. or “UMG” for about $4 billion, representing an enterprise value of 35 billion euros for UMG.

Getty